This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Pharma Mar, S.a.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Cármen Cuevas Marchante: Innovator in Antibody Drug Conjugates
Introduction
Cármen Cuevas Marchante is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug therapies. His work focuses on antibody drug conjugates, which are crucial in the treatment of cancer.
Latest Patents
Cármen Cuevas Marchante holds a patent for antibody drug conjugates. The patent describes drug conjugates of the formula [D-(X)b-(AA)w-(L)-]n-Ab, where D represents a drug moiety with specific chemical properties. This invention is designed to enhance the efficacy of cancer treatments by targeting specific antigens.
Career Highlights
Cármen is currently associated with Pharma Mar, S.A., a leading biopharmaceutical company. His work at Pharma Mar has been instrumental in advancing cancer therapies through innovative drug development. He has a proven track record of research and development in the pharmaceutical industry.
Collaborations
Cármen has collaborated with various professionals in the field, including his coworker, Andrés Francesch Solloso. These collaborations have fostered a productive environment for innovation and research in drug development.
Conclusion
Cármen Cuevas Marchante is a pioneering inventor whose work in antibody drug conjugates is making a significant impact in cancer treatment. His contributions to Pharma Mar and the pharmaceutical industry highlight the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile